Beijing Tongrentang CoSHSE:600085 +3.17%76 EV-to-FCF is 13.50 as of Jul. 13, 2026, which is 47% below its 10-year median of 25.49. GuruFocus rates SHSE:600085 with a GF Score™ of 76/100 and a GF Value™ of ¥35.35 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 562 Drug Manufacturers companies, Beijing Tongrentang Co ranks better than 67.62% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Beijing Tongrentang Co's Enterprise Value is ¥33,343 Mil.
Beijing Tongrentang Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ¥2,469 Mil. Therefore, Beijing Tongrentang Co's EV-to-FCF for today is 13.50.
The historical rank and industry rank for Beijing Tongrentang Co's EV-to-FCF or its related term are showing as below:
SHSE:600085'
s EV-to-FCF Range Over the Past 10 Years
Min: -60.73 Med: 25.49 Max: 633.24
Current: 13.5
During the past 13 years, the highest EV-to-FCF of Beijing Tongrentang Co was 633.24. The lowest was -60.73. And the median was 25.49.
SHSE:600085's EV-to-FCF is ranked better than 67.62% of 562
companies
in the Drug Manufacturers industry
Industry Median: 20.955
vs SHSE:600085: 13.50
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Beijing Tongrentang Co (SHSE:600085) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Beijing Tongrentang Co's PE Ratio (TTM) for today is calculated as:
Beijing Tongrentang Co's share price for today is ¥24.43.
Beijing Tongrentang Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.785.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Tongrentang Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Tongrentang Co EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Beijing Tongrentang Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Beijing Tongrentang Co's EV-to-FCF falls into.
Beijing Tongrentang Co's current Enterprise Value is ¥33,343 Mil.
Beijing Tongrentang Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,469 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Tongrentang Co (SHSE:600085) has a EV-to-FCF of 13.50 as of Jul. 13, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Beijing Tongrentang Co and its competitors. This is 47% below median its historical median of 25.49. According to the industry distribution chart, Beijing Tongrentang Co ranks #182 out of 562 companies in the Drug Manufacturers industry, placing it in the top 32.4%.
Is Beijing Tongrentang Co's EV-to-FCF too high?
Beijing Tongrentang Co's current EV-to-FCF of 13.50 is 47% below median its 10-year median of 25.49. The Drug Manufacturers industry median EV-to-FCF is 20.96. Beijing Tongrentang Co's value of 13.50 is 35.6% below this industry median. Based on the distribution chart, Beijing Tongrentang Co ranks #182 out of 562 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Beijing Tongrentang Co has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Tongrentang Co's EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Beijing Tongrentang Co ranks #182 out of 562 companies for EV-to-FCF. This puts Beijing Tongrentang Co in the upper half of its industry. The industry median EV-to-FCF is 20.96. Beijing Tongrentang Co's value of 13.50 is 35.6% below this benchmark. While the company's 10-year median is 25.49 vs. the industry median of 20.96, Beijing Tongrentang Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.96, based on 562 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Tongrentang Co's current EV-to-FCF of 13.50 is 35.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Beijing Tongrentang Co and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Tongrentang Co's current EV-to-FCF is 13.50, which is 47% below median its own 10-year median of 25.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Tongrentang Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Tongrentang Co (SHSE:600085) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥35.35, compared to a current price of ¥24.43 — trading 30.9% below its estimated fair value. The current EV-to-FCF is 13.50, which is 47% below median its 10-year median of 25.49 and 35.6% below the Drug Manufacturers industry median of 20.96. Beijing Tongrentang Co's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Beijing Tongrentang Co (SHSE:600085), the current EV-to-FCF is 13.50 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Tongrentang Co (SHSE:600085) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Tongrentang Co stock appears to be undervalued.
The current stock price of ¥24.43 is trading 30.9% below its estimated GF Value™ of ¥35.35.
GuruFocus considers Beijing Tongrentang Co to be Significantly Undervalued.
Key valuation signals for SHSE:600085:
EV-to-FCF: 13.50 (47% below median its 10-year median of 25.49)
GF Value™: ¥35.35 vs. price of ¥24.43 (30.9% below fair value)
Industry Position: 35.6% below the Drug Manufacturers median (#182 of 562)
No single metric tells the full story. See the SHSE:600085 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Tongrentang Co Ltd is a China-based company operating in the traditional Chinese medicinal industry. The company produces modern pharmaceuticals and operates retail businesses and medical services. The company's main products consist of Liuwei Dihuang series, Tongren Dahuoluo series, Tongren Niuhuang Qingxin series, Angong Niuhuang series, and Donkey-hide gelatin series. It distributes its products under the brand of Tongrentang.
76GF Score
Get the complete analysis for SHSE:600085
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600085 has been successfully added to your 
